medigraphic.com
ISSN 1405-1710 (Print)

2018, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2018; 27 (1)

Kawasaki disease. Communication of two cases

Marín-Hernández E, Vidal-Flores AA, Sámano-Aviña M, Delfín-Sánchez YL

Language: Spanish
References: 16
Page: 12-18
PDF size: 297.11 Kb.


ABSTRACT

Kawasaki disease (KD) is a vasculitis of the small and medium sized vessels, of unknown etiology. It is most often seen in children between six months and five years of age. The diagnostic criteria include fever for at least five days, accompanied by at least four of five criteria. Incomplete forms have been described in patients who do not meet all clinical criteria for classical KD. In this article we report the case of two patients, one with diagnosis of complete KD who does not respond to treatment with intravenous immunoglobulin, requiring a second administration, and another with incomplete KD, who presents adequate response to conventional treatment.


REFERENCES

  1. Bayers S, Shulman ST, Paller AS. Kawasaki disease. Part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013; 69: 501.

  2. Kuo CH, Yang KD, Chang WC, Ger LP, Hsieh KS. Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol. 2012; 53: 4-11.

  3. Molina PA, Mendieta AG. Enfermedad de Kawasaki, curso clínico y evolución. Arch Inv Mat Inf. 2010; 2: 128-133.

  4. Parra MP, Rivera RL, Yamazaki NMA, Nava GF, Rodríguez AJ, Bolaños RR. Enfermedad de Kawasaki refractaria, incompleta y atípica. Informe de un caso y revisión de la bibliografía. Arch Cardiol Mex. 2011; 81: 221-227.

  5. Prieto TL, Cuesta RM, Guillén MS, Ruiz JM, Cortés CM, Rubio GB et al. Enfermedad de Kawasaki: diagnóstico y tratamiento. An Pediatr (Barc). 2010; 73: 25-30.

  6. Morales QJ, Espinola ZN, Caballero CR, García LJ, Rodríguez QJ, Betanzos RL. Enfermedad de Kawasaki: evolución y complicaciones cardiovasculares en niños. Rev Med Inst Mex Seguro Soc. 2011; 49: 295-300.

  7. Kim JH, Yu JJ, Lee J, Kim MN, Ko HK, Choi HS et al. Detection rate and clinical impact of respiratory visruses in children with Kawasaki disease. Korean J Pediatr. 2012; 55: 470-473.

  8. Rowley AH, Shulman ST. Missing the forest for the trees: respiratory viral assay in patients with Kawasaki disease. Clin Infect Dis. 2013; 56: 65-66.

  9. Kemmotsu Y, Saji T, Kusunoki N, Tanaka N, Nishimura C, Ishiguro A, Kawai S. Serum adipokine profiles in Kawasaki disease. Mod Rheumatol. 2012; 22: 66-72.

  10. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011; 43: 1241-1246.

  11. Burns JC, Newburger JW. Genetics insights into the pathogenesis of Kawasaki disease. Circ Cardiovasc Genet. 2012; 5: 277-278.

  12. Victoria J. Detección temprana de la enfermedad de Kawasaki. CCAP. 2014; 13: 36.

  13. Cardozo LM, Escobar BA, Alvarán MM, Londoño RJD. Kawasaki disease: diagnosis and treatment. CES Med. 2012; 26: 261.

  14. Forsey J, Mertens L. Atypical Kawasaki disease- a clinical challenge. Eur J Pediatr. 2012; 171: 609-611.

  15. Chen J, Liu Y, Liu W, Wu Z. A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in chinese children. J Huazhong Univ Sci Technolog Med Sci. 2011; 31: 705-711.

  16. Manlhiot C, Christie E, McCrindle BW, Rosengerg H, Chahal N, Yeung RS. Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr. 2012; 171: 657-662.




2020     |     www.medigraphic.com